The FDA has approved Juviderm Ultra XC for lip augmentation in adults ages 21 or older.
This weekly video program highlights the latest in pharmacy news, product news, and more.
As Hurricane Joaquin blasts the Bahamas, many have feared that the storm would travel north to the East Coast.
More children than previously thought have trouble sleeping, and a third of them are given medication for it.
The FDA is considering approval for an intranasal formulation of the opioid overdose antidote naloxone (Narcan).
Now that fall is in full gear, patients will soon start traveling to see loved ones during the holiday season.
The changeover to ICD-10 medical diagnosis codes could complicate tasks in emergency departments.
The FDA is considering approval for Sanofi’s lixisenatide type 2 diabetes treatment.
Adding an antipsychotic to an antidepressant regimen may relieve treatment-resistant depression in seniors.
October is American Pharmacists Month, the perfect time to promote the pharmacy profession and recognize the important role of the pharmacist.
Asthma and chronic obstructive pulmonary disease (COPD) occur together at an alarming rate.
Approximately 65% of individuals undergoing chemotherapy will experience chemotherapy-induced hair loss, which is usually temporary and completely reversible when therapy ends.
If you are receiving radiation and chemotherapy for cancers of the head and neck, you may experience oral mucositis.
Peptic ulcer disease leads to 1 million hospitalizations and 6500 deaths annually.
Dietary supplements are intended to supplement the diet, not to cure, prevent, or treat diseases or replace the variety of foods important to a healthy diet.
Strategic Alliance Partners